WELL Health Technologies Corp. (TSE:WELL) Receives C$7.13 Average Price Target from Analysts

WELL Health Technologies Corp. (TSE:WELL) has been given an average recommendation of “Moderate Buy” by the six brokerages that are currently covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is C$7.13.

Separately, Stifel Nicolaus lowered their price objective on WELL Health Technologies from C$11.00 to C$10.00 in a research note on Monday, April 29th.

WELL Health Technologies Stock Performance

Shares of WELL Health Technologies stock opened at C$4.87 on Tuesday. The company has a debt-to-equity ratio of 48.62, a quick ratio of 1.02 and a current ratio of 1.48. The firm’s 50-day simple moving average is C$4.35 and its 200-day simple moving average is C$4.00. WELL Health Technologies has a 1 year low of C$3.41 and a 1 year high of C$5.05. The firm has a market cap of C$1.20 billion, a PE ratio of 40.58, a price-to-earnings-growth ratio of -1.93 and a beta of 1.24.

Insider Buying and Selling

In other news, Senior Officer Eva Fong sold 10,000 shares of the business’s stock in a transaction on Friday, July 5th. The stock was sold at an average price of C$4.80, for a total transaction of C$48,000.00. 6.83% of the stock is currently owned by insiders.

About WELL Health Technologies

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.